Walgreens Boots Alliance Inc. (WBA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Walgreens: So Bad It's Good Heading Into Earnings (Rating Upgrade)
Walgreens (WBA) faces a challenging outlook with weak profit forecasts and negative EPS revisions, but technical signals suggest a potential upside, prompting a buy rating. Despite bearish trends and a recent dividend cut, WBA's valuation metrics are extremely low, making it a high-risk, potentially undervalued investment. Key risks include a shift away from physical stores and commercial real estate weakness, but WBA's free cash flow remains positive, mitigating immediate cash-burn concerns.
Walgreens stock is cheap and oversold: is it a value trap?
Walgreens Boots Alliance (WBA) has become a fallen angel, costing investors billions of dollars in the past few years. Its stock has imploded, falling from $69 in 2014 to $9 today, meaning that a $1000 investment at its top would now be worth just $130.
5 Things You Need to Know If You Buy Walgreens Today
Walgreens stock is taking a hit, in part, because of prescription reimbursement pressures from insurers. Walgreens also made a poor acquisition that continues to weigh on its results.
Walgreens Boots Alliance Is Oversold
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Walgreens Boots Alliance presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.
Should You Buy Walgreens Boots Alliance for Its 11.1% Dividend Yield? 3 Things to Know First
High dividend yields can trick investors into buying low-quality or distressed stocks. Walgreens faces several challenges that have deteriorated its fundamentals.
Walgreens Boots Alliance (WBA) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $8.53, indicating a -0.35% shift from the previous trading day.
WBA Stock Dips 5% Post Fed Rate Cut: Should You Sell Walgreens Boots?
WBA is currently facing challenges within its U.S. Retail Pharmacy segment due to an unfavorable consumer environment and adverse pharmacy industry trends.
3 Reasons Why Walgreens Boots Alliance Stock May Not Be Doomed
Walgreens is struggling and is considering closing stores and selling assets. It brought on a new CEO last year who appears to be considering a wide range of possible moves for the business.
Walgreens Boots Alliance (WBA) Suffers a Larger Drop Than the General Market: Key Insights
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $9.01, indicating a -0.55% shift from the previous trading day.
Walgreens Boots Alliance, Inc. Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 12, 2023 and June 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Walgreens Boots Alliance Inc
LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 12, 2023 and June 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.
Where Will Walgreens Boots Alliance Be in 3 Years?
Walgreens Boots Alliance does not have big plans for the next three years. It may need to undergo more painful cost cuts, downsizing, and deleveraging.
